Clinical Trials Browser

Enrolling by invitation × tislelizumab × 90 days × Clear all

NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Phase 1 Enrolling by invitation

Lymphatic Metastasis